/

|

Johnson & Johnson (NYSE: JNJ), has broken ground on a $2 billion pharmaceutical manufacturing facility in Wilson, about 50 miles east of Raleigh. The project is part of a larger, $55 billion investment in U.S. manufacturing, research-and-development (R&D) and technology initiatives that the global pharmaceutical, medical devices and consumer health products provider is planning over the next four years.

“Today’s announcements accelerate our nearly 140-year legacy as an American innovation engine tackling the world’s toughest healthcare challenges,” says Joaquin Duato, chairman and CEO of Johnson & Johnson. “Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world.”